THE TAPE
$545.65▼ −0.87%
Last close
Relative strength
35RS
of 99, against every stock▲ +10 on the month
Turning up
Unconfirmed
−1.0%
six months against the S&P 500
52-week range
−29.5%
from the high
$470.06$774.00
Setup
blue skyplayed out
−14.9%
against the pivot at $640.90
No report date on the calendar.
Growth FLATProof SHOWN
Quarter to Sep 30, revenue +7% on a year ago
11/16 O 553.98 H 555.00 L 542.93 Vol 830.9K
Draw
9-dayabout two weeks21-dayabout a month50-dayabout a quarter200-dayabout a year

The four are not in order. That is a description of where the averages sit, not a view about what happens next.

RS35
vs pivot−14.86%
Tightening0.84×
Dry-up0.95×
Up/down vol-0.09
From high30%
played out1 of 9checks
Turning up
Support and resistance
Support below
$540.48
-0.9% · tested 6× · last 13 sessions ago
Resistance above
$555.26
+1.8% · tested 8× · last 2 sessions ago

Prices this stock has turned at three or more times in the last 120 sessions, with how many times. Where buyers and sellers showed up before, not a forecast, an entry or a stop.

The read

The base has run 13.2 weeks and fell 15% from its ceiling at its deepest. The pivot is $640.90, and the stock closed 14.9% below it. Its relative strength rating is 35.

Against its industry
UnconfirmedNone of the patterns above holds.
One month against the S&P 500
+8.3%
Three months against the S&P 500
-3.9%
Six months against the S&P 500
-1.0%

Its industry has too few members to make an index of, so it is read against the S&P 500 and can only be turning, caution or unconfirmed.

Peers
Catalyst roadmap

Nothing dated in the next three months that we can ingest automatically.

How it moves on earnings

On average 5.5% either way across its last 8 reports.

Checking your subscription…

Close before the report day to close after it, so it holds whether the company reported before the open or after the close.

The business
Revenue
$43.6B
+6.7% year on year
Operating margin
10.6%
Net margin
10.4%
Free cash flow
$3.8B
4.9% of market cap
Price to sales
1.78×
Price to earnings
17.1×

Twelve months to Sep 30, 2026, the four latest quarters in the company’s SEC filings, with the fiscal fourth quarter worked out from the annual report. Revenue growth is the latest quarter against the same quarter a year earlier.

The latest quarter, read by fixed rules · reported Oct 20
Key takeaway
Profitable and cash generating; the question is growth.
Revenue
$11.1B
+2.3% QoQ · +6.7% YoY
Gross margin
—
Net income
$1.1B
Positive
Free cash flow
$1.4B
Cash generating

What the numbers say

  • Revenue +6.7% year over year, +2.3% on the quarter
  • Good: Profitable: net income $1.12B, operating margin 11.4%
  • Good: Cash generating: operating cash flow $1.75B, free cash flow $1.44B
  • Net debt $11.45B · cash $3.74B
Revenue by quarter
Free cash flow
Net income
shares -0.8% in a year · net debt $11.5B

What is not obvious

  • Contracted backlog (remaining performance obligations) $109.60B, 2.5× trailing revenue, +5% on the quarter. Backlog is not recognised revenue
Final read
Growth: FLAT · Economic proof: SHOWN
Key question: Can the cash generation hold as growth slows?
The next test is whether the quarter repeats.

From the company’s 10-Q and 10-K filings, by Market Desk’s rules. Every line, the takeaway and the final read are fixed rules on the filed numbers; nothing reads the press release, and none of it enters a screen or a rating. Every recent reporter.

Tracked funds

Held by 3 of 46 tracked funds at the end of Q3 2026.

Last quarter: 2 added.

Checking your subscription…

From 13F filings, which show long stock only and arrive up to 45 days after the quarter. The broad quant funds are left out.

Flagged by the market sweep
Tightening after a sharp runTape · 2026-10-28
range halved after a +17% thrust, at 551.23
No measurable effect: stocks behave like random ones over the next three sessions (887 cases over 60 nights).
Reported resultsFiling · 2026-10-21
2.02
No measurable effect: stocks behave like random ones over the next three sessions (2,340 cases over 54 nights).
New 52-week lowTape · 2026-10-05
3.3x vol
Mixed: stocks have outrun random stocks by 0.6% over three sessions, not consistently enough to call (746 cases over 51 nights). Against their own sector they have outrun by 0.2%.
Unusual volumeTape · 2026-10-05
6.8 sigma
After this signal, stocks have lagged random stocks by 0.1% over the next three sessions (6,474 cases over 55 nights). Against their own sector they have lagged by 0.4%.

From a separate overnight market sweep, not from the screens on this site. What it flagged, not what it means. The track record is the sweep's own, measured against random stocks over the last 90 days.

In the news
Insiders
Bought on the open market
0
Sold on the open market
12
$93,172 total

Sold: WELSH MARK A III.

Not counted above: 6 filings for awards, option exercises, gifts or shares withheld to pay tax. Those follow a vesting schedule nobody chose the timing of, and counting them as selling is how that number gets misread.

Most recent filings
2026-11-02 WELSH MARK A III · Directorsell7$3,874
2026-11-02 WELSH MARK A III · Directorsell20$11,109
2026-11-02 WELSH MARK A III · Directorsell50$27,824
2026-11-02 WELSH MARK A III · Directorsell1$557
2026-11-02 Davies Benjamin R. · CVP & Pres. Defense Systemsoption exercise641
2026-11-02 Davies Benjamin R. · CVP & Pres. Defense Systemswithheld for tax281$156,045
2026-09-30 KRISHNA ARVIND · Directoraward75$36,261
2026-09-30 Brown Marianne Catherine · Directoraward96$46,414

From SEC Form 4, filed within two business days of the trade. What was filed, not what it means.

What lines up

1 of 9 published checks currently line up. This is a count, not a probability — nothing on this site measures how often a setup works.

Relative strength of 80 or better
Above its 50-day line
Above its 200-day line
Averages fully stacked
Within 5% of its pivot
Range tightening through the base
Volume drying up through the base
More up-volume than down-volume
Within 15% of its 52-week high
What analysts expect
Strong buy3
Buy13
Hold9
Sell0
Strong sell1

These are analysts’ estimates, not ours, and not a projection this site endorses. They are published here because what the sell side expects is itself a fact about the market.

Checking your subscription…

Gamma concentration

No option open interest for this company. Most listed names have no options at all, and we only read chains for names carrying a dated event, so this is a normal reading rather than a fault.

X-ray

The most recent of 2 completed bases.

Checking your subscription…

A screening and market-analytics tool. Not investment advice. We are not a registered investment adviser. A stock on a screen matches a shape; that is not a prediction. Prices are end-of-day, not live.

What that means, in full
Northrop Grumman Corp. (NOC) — The Tape